GLAUKOS Corp (GKOS)
Health Care / Health Care Equipment
S&P SmallCap 600$112.57
Below average on several measures. Research carefully.
Weak
Score based on 3 of 5 models — moderate confidence
Is GLAUKOS Corp a Good Investment in 2026?
GLAUKOS Corp (GKOS) scores 4.3 out of 10 on AlphaStocks' composite model, earning a Weak rating. The Piotroski model is the most favorable, rating GLAUKOS Corp as Caution. However, the Graham model rates it Caution. GLAUKOS Corp ranks #777 out of 1127 stocks in the Health Care sector.
This summary is algorithmically generated and is not financial advice.
Key Metrics
Valuation
Currently unprofitable — fair value estimate not available.
Fair value estimate not available for this stock.
5-Model Analysis
Each model evaluates this stock from a different angle. Combined, they form the composite score above.
Piotroski
Caution
2/9
Buffett
Caution
Business quality & competitive moat
Graham
Caution
Price vs intrinsic value
Lynch
Limited Data
Growth rate vs price (PEG)
Greenblatt
Limited Data
Earnings yield + return on capital
Frequently Asked Questions
Is GLAUKOS Corp (GKOS) a good investment?
What is GLAUKOS Corp's Piotroski F-Score?
Is GKOS overvalued or undervalued?
How does GKOS compare to other Health Care stocks?
What do investment models say about GKOS?
Similar Stocks
Compare GKOS with
Scores are algorithm-generated research tools, not investment recommendations. Past performance does not guarantee future results. Always do your own due diligence. Full disclaimer